In the last trading session, 1.05 million Relmada Therapeutics Inc (NASDAQ:RLMD) shares changed hands as the company’s beta touched 0.39. With the company’s per share
During the last session, Relmada Therapeutics Inc (NASDAQ:RLMD)’s traded shares were 0.52 million, with the beta value of the company hitting 0.42. At the end
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
